CoChat

An assessment of sex bias in neurodevelopmental disorders

Open access

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Neurodevelopmental disorders such as autism and intellectual disability have a sex bias skewed towards boys; however, systematic assessment of this bias is complicated by the presence of significant genetic and phenotypic heterogeneity of these disorders. METHODS: To assess the extent and characteristics of sex bias, we analyzed the frequency of comorbid features, the magnitude of genetic load, and the existence of family history within 32,155 individuals ascertained clinically for autism or intellectual disability/developmental delay (ID/DD), including a subset of 8,373 individuals carrying rare copy-number variants (CNVs). RESULTS: We find that girls were more likely than boys to show comorbid features within both autism (P = 2.9 × 10(-6), OR = 1.34) and ID/DD (P = 7.2 × 10(-4), OR = 1.08) cohorts. The frequency of comorbid features in ID/DD was higher in boys (1q21.1 deletion, 15q11.2q13.1 duplication) or girls (15q13.3 deletion, 16p11.2 deletion) carrying specific CNVs associated with variable expressivity while such differences were the smallest for syndromic CNVs (Smith-Magenis syndrome, DiGeorge syndrome). The extent of the male sex bias also varied according to the specific comorbid feature, being most extreme for autism with psychiatric comorbidities and least extreme for autism comorbid with epilepsy. The sex ratio was also specific to certain CNVs, from an 8:1 male:female ratio observed among autistic individuals carrying the 22q11.2 duplication to 1.3:1 male:female ratio in those carrying the 16p11.2 deletion. Girls carried a higher burden of large CNVs compared to boys for autism or ID/DD, and this difference diminished when severe comorbidities were considered. Affected boys showed a higher frequency of neuropsychiatric family histories such as autism (P = 0.01) or specific learning disability (P = 0.03), while affected girls showed a higher frequency of developmental family histories such as growth abnormalities (P = 0.02). CONCLUSIONS: The sex bias within neurodevelopmental disorders is influenced by the presence of specific comorbidities, specific CNVs, mutational burden, and pre-existing family history of neurodevelopmental phenotypes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13073-015-0216-5

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic of cohorts derived from the clinical testing population. The schematic shows datasets derived from the Signature Genomics clinical testing population including the filtering of CNV calls to remove false-positive detection. Note that CNVs were removed if there was a >10 % overlap with a list of artifact CNV calls (Additional file 1: Table S2). Rare CNVs were derived after removing the CNV calls greater than 0.1 % frequency in a control cohort (>8/8,329 controls)
Fig. 1 Schematic of cohorts derived from the clinical testing population. The schematic shows datasets derived from the Signature Genomics clinical testing population including the filtering of CNV calls to remove false-positive detection. Note that CNVs were removed if there was a >10 % overlap with a list of artifact CNV calls (Additional file 1: Table S2). Rare CNVs were derived after removing the CNV calls greater than 0.1 % frequency in a control cohort (>8/8,329 controls)CC BY · PubMed Central
Fig. 2 Comorbidity within autism and ID/DD. The frequency of comorbid features within (a) all cases with autism (n = 5,872), boys (n = 4,588) and girls (n = 1,284) with autism, and within (b) all individuals with ID/DD (n = 28,553), boys (n = 17,061) and girls (n = 11,492) with ID/DD is shown. The frequency of comorbid features within (c) girls (F) and boys (M) is shown for a representative set of genomic disorders. Additional file 1: Table S8 shows data for all CNVs with sample sizes >10. Due to a limited sample size within the genomic disorder cohort, only ID/DD can be shown. Samples sizes for the CNVs are: 1q21.1 del: M = 30, F = 21; 15q13.3 del: M = 25, F = 20; 16p11.2 del: M = 45, F = 29; 16p12.1 del: M = 20, F = 9; 16p13.11 del: M = 25, F = 26; 1q21.1 dup: M = 27, F = 20; 15q11.2q13.1 dup (Prader-Willi region dup): M = 26, F = 21; 16p11.2 dup: M = 29, F = 16; 16p13.11 dup: M = 25, F = 26; 22q11.2 del (DiGeorge Syndrome): M = 35, F = 30; Smith Magenis Syndrome (SMS): M = 10, F = 13; 22q13 del: M = 11, F = 34
Fig. 2 Comorbidity within autism and ID/DD. The frequency of comorbid features within (a) all cases with autism (n = 5,872), boys (n = 4,588) and girls (n = 1,284) with autism, and within (b) all individuals with ID/DD (n = 28,553), boys (n = 17,061) and girls (n = 11,492) with ID/DD is shown. The frequency of comorbid features within (c) girls (F) and boys (M) is shown for a representative set of genomic disorders. Additional file 1: Table S8 shows data for all CNVs with sample sizes >10. Due to a limited sample size within the genomic disorder cohort, only ID/DD can be shown. Samples sizes for the CNVs are: 1q21.1 del: M = 30, F = 21; 15q13.3 del: M = 25, F = 20; 16p11.2 del: M = 45, F = 29; 16p12.1 del: M = 20, F = 9; 16p13.11 del: M = 25, F = 26; 1q21.1 dup: M = 27, F = 20; 15q11.2q13.1 dup (Prader-Willi region dup): M = 26, F = 21; 16p11.2 dup: M = 29, F = 16; 16p13.11 dup: M = 25, F = 26; 22q11.2 del (DiGeorge Syndrome): M = 35, F = 30; Smith Magenis Syndrome (SMS): M = 10, F = 13; 22q13 del: M = 11, F = 34CC BY · PubMed Central
Fig. 3 Sex ratio for specific comorbidities in individuals with autism and ID/DD. The male:female ratio of individuals manifesting (a) autism, and (b) ID/DD, with specific comorbidities is shown. For this analysis, the other congenital malformations category also included growth abnormalities, kidney malformations, cardiac malformations, and dysmorphic features. Sample sizes (n) for each combination of comorbid features (with autism or ID/DD) is provided in Additional file 1: Table S9
Fig. 3 Sex ratio for specific comorbidities in individuals with autism and ID/DD. The male:female ratio of individuals manifesting (a) autism, and (b) ID/DD, with specific comorbidities is shown. For this analysis, the other congenital malformations category also included growth abnormalities, kidney malformations, cardiac malformations, and dysmorphic features. Sample sizes (n) for each combination of comorbid features (with autism or ID/DD) is provided in Additional file 1: Table S9CC BY · PubMed Central
Fig. 4 Sex ratio for individuals with autism or ID/DD also carrying specific CNVs. The male:female ratio of individuals carrying specific deletions and duplications also manifesting features of (a) autism and (b) ID/DD. Sample sizes (n) for each CNV is provided in Additional file 1: Table S10
Fig. 4 Sex ratio for individuals with autism or ID/DD also carrying specific CNVs. The male:female ratio of individuals carrying specific deletions and duplications also manifesting features of (a) autism and (b) ID/DD. Sample sizes (n) for each CNV is provided in Additional file 1: Table S10CC BY · PubMed Central
Fig. 5 CNV burden in autism and ID/DD cohorts. Population frequency of the largest CNV in individuals with autism, ID/DD, epilepsy, and/or other comorbidities is shown. Using the rare CNV cohort, survivor functions were generated for the population frequency carrying a CNV larger than a given size. CNV burden plots are shown for: (a) boys (dashed lines) and girls (solid lines) with autism with or without any comorbidities; (b) boys (dashed lines) and girls (solid lines) with ID/DD with or without any comorbidities; (c) boys (dashed lines) and girls (solid lines) with autism with ID, autism with epilepsy, and ID with epilepsy are shown. Full statistical analysis including sample sizes (n) is provided in Additional file 1: Table S11
Fig. 5 CNV burden in autism and ID/DD cohorts. Population frequency of the largest CNV in individuals with autism, ID/DD, epilepsy, and/or other comorbidities is shown. Using the rare CNV cohort, survivor functions were generated for the population frequency carrying a CNV larger than a given size. CNV burden plots are shown for: (a) boys (dashed lines) and girls (solid lines) with autism with or without any comorbidities; (b) boys (dashed lines) and girls (solid lines) with ID/DD with or without any comorbidities; (c) boys (dashed lines) and girls (solid lines) with autism with ID, autism with epilepsy, and ID with epilepsy are shown. Full statistical analysis including sample sizes (n) is provided in Additional file 1: Table S11CC BY · PubMed Central
Fig. 6 Family history among individuals with neurodevelopmental phenotypes. Matrices were generated showing percentage of individuals with a clinical indication and a specific family history among all individuals with that specific indication and any family history: boys (left, n = 236) and girls (right, n = 150). Family history is represented on the Y-axis, and the clinical indication of the proband is on the X-axis. The frequency of family history is depicted as a range of colors. A graphical description of the comparisons made is provided in Additional file 1: Figure S4
Fig. 6 Family history among individuals with neurodevelopmental phenotypes. Matrices were generated showing percentage of individuals with a clinical indication and a specific family history among all individuals with that specific indication and any family history: boys (left, n = 236) and girls (right, n = 150). Family history is represented on the Y-axis, and the clinical indication of the proband is on the X-axis. The frequency of family history is depicted as a range of colors. A graphical description of the comparisons made is provided in Additional file 1: Figure S4CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Cited by

See all 149

Metadata

Authors
Polyak, A., Rosenfeld, J. A., & Girirajan, S.
Affiliations
  • Pennsylvania State University (US)
  • Baylor College of Medicine (US)
Corresponding author
Girirajan, Santhosh
Venue
Genome Medicine
Published
2015-08-27
Volume
7
Issue
1
Pages
94-94
ISSN
1756-994X (ISSN-L)
OpenAlex
W1950769362
Cited by
129
References
65
Citations by year
2026: 8 · 2025: 11 · 2024: 20 · 2023: 18 · 2022: 11 · 2021: 12 · 2020: 18 · 2019: 13 · 2018: 8 · 2017: 5 · 2016: 5
FWCI
4.12
Type
journal article
Language
en
Open access
Locations
  • Genome Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • March of Dimes Foundation (US) (#5-FY14-66)
  • Brain and Behavior Research Foundation (US) (22535)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
sex bias, neurodevelopmental disorders, autism spectrum disorder, intellectual disability, developmental delay, copy number variation, comorbidities, psychiatric comorbidity, epilepsy, 1q21.1 deletion, 16p11.2 deletion, 22q11.2 duplication, variable expressivity, family history (medicine), genetic load, sex ratio
MeSH terms
Adolescent, Adult, Child, Child, Preschool, Female, Humans, Infant, Male, Phenotype, Sex Factors, Comorbidity, Odds Ratio, Young Adult, DNA Copy Number Variations, Neurodevelopmental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An assessment of sex bias in neurodevelopmental disorders. https://app.cochat.ai/papers/10.1186/s13073-015-0216-5
The paper
Polyak, A., Rosenfeld, J. A., & Girirajan, S. (2015). An assessment of sex bias in neurodevelopmental disorders. Genome Medicine. https://doi.org/10.1186/s13073-015-0216-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.